View Older Stories View More Recent Stories
-
Lion Biotech's (LBIO) Collaboration with MedImmune (AZN) Indicates Increasing TIL Interest - Roth Capital
-
Roth Affirms Horizon Global (HZN) at 'Buy' Following Investor Meetings; Facility Consolidation on Schedule
-
Iradimed Corp. (IRMD) Prices 1.04M Common Secondary Offering at $24.25/Share
-
IRADIMED CORPORATION Announces Pricing of Secondary Offering of Common Stock
-
Roth Positive on Ligand's (LGND) Move to Acquire OMT; Bumps PT to $146
-
Uranium Resources (URRE) Announces $1M Equity Raise
-
Uranium Resources Announces $1.0 Million Funding
-
Iradimed Corp. (IRMD) CEO to Offer Stock
-
IRADIMED CORPORATION Announces Proposed Secondary Offering of Common Stock
-
Roth Capital Starts Upland Software (UPLD) at Buy
-
Hydrogenics Announces Closing of Underwritten Public Offering and Full Exercise of Over-Allotment Option
-
Unusual 11 Mid-Day Movers 12/16: (ACST) (JRJC) (ENPH) Higher; (ACI) (RPXC) (MG) Lower
-
Notable Analyst Rating Changes 12/16: (CHRW) (BYD) (BEAV) Upgraded; (OREX) (LPT) (KMT) Downgraded
-
Roth Capital Upgrades ReneSola Ltd. (SOL) to Buy
-
Roth Capital Upgrades JA Solar Holdings Co., Ltd. (JASO) to Buy
-
UPDATE: BTC Renewal is Material Positive for Darling Ingredients (DAR) Joint Venture; Roth Affirms at 'Buy'
-
Roth Capital Upgrades Enphase Energy (ENPH) to Buy
-
SolarCity (SCTY) PT Raised to $65 at Roth Capital Following Analyst Day
-
Spark Therapeutics (ONCE) Prices 3M Common Offering at $47/Share
-
Spark Therapeutics Announces Pricing of Public Offering
-
Facebook's (FB) 'Professional Services' Testing May Challenge Yelp (YELP) Prospects - Roth Capital Reiterates Sell
-
Roth Capital Cuts Price Target on Crossroads Systems (CRDS) Following Mixed 4Q Results
-
Spark Therapeutics (ONCE) Announces 3M Common Stock Offering
-
Spark Therapeutics Announces Launch of Public Offering
-
Roth Reaffirms Canadian Solar (CSIQ) at 'Buy' Following Meetings with Management; 2016 Shaping up Well
-
Viralytics Completes $28 million Placement -- SPP to Follow
-
XPEL to Attend Third Annual ROTH New Industrials Corporate Access Day
-
Hydrogenics (HYGS) Prices 2.13M Common Stock Offering at $7.75/Share
-
Hydrogenics Announces Pricing and Upsizing of Public Offering of Common Shares
-
First Direct Lending, LLC Appoints John Hamel as EVP of Capital Markets
-
Inphi (IPHI) PT Lifted at Roth Capital, Sees Lots of Shots On Goal
-
New InvenSense (INVN) Products Will Diversify Revenue Dependence on Apple and Samsung - Roth Capital
-
Quantum Materials to Participate in ROTH Capital Partners New Industrials Corporate Access Day
-
Roth Believes BioBlast (ORPN) Management Made Prudent Decision with Cabaletta Phase 2b
-
ROTH Capital Partners to Host Immuno-Oncology Corporate Access Day in New York on December 16, 2015
-
Krispy Kreme (KKD) PT Trimmed to $24 at Roth Capital Post Q3; Buy Maintained on Strength in Store Margins
-
Outerwall (OUTR) PT Cut to $61.50 at Roth Capital with Redbox Weak as Expected
-
Delta Apparel, Inc. to Attend the 4th Annual ROTH Utah Healthy & Active Lifestyle Conference
-
Delta Apparel, Inc. to Attend the 4th Annual ROTH Utah Healthy & Active Lifestyle Conference
-
Notable Analyst Rating Changes 12/7: (ABT) (NSC) (MCC) Upgraded; (CMG) (BLUE) (ARMH) Downgraded
-
ROTH Capital Partners to Host New Industrials Corporate Access Day
-
Great Basin Announces Modifications to Series C Warrants
-
Hydrogenics (HYGS) Announces $15M Common Stock Offering
-
Roth Capital Downgrades bluebird bio (BLUE) to Neutral Amid Latest Thalassemia Patient Data
-
Hydrogenics Announces Proposed Public Offering of Common Shares
-
Roth Capital Downgrades bluebird bio (BLUE) to Neutral
-
Marchex to Present at Investor Conference
-
CTI BioPharma (CTIC) Prices $55M Conv. Preferred Offering
-
CTI BioPharma Prices Underwritten Public Offering of $55 Million of Convertible Preferred Stock
-
Galena Biopharma (GALE) Takes Big Step Forward with Class Action Settlement; Roth Affirms at 'Buy'

